KRAS and lung cancer: Hollstein et al. [37] used CRISPR technology to study the role of SIK in Kras-G12D mice and found that loss of SIK1 and SIK3 redundantly mediated the tumor-suppressor activity of LKB1 and accelerated tumor growth in KRAS-driven lung cancer.